Introduction: Keloid scars and hypertrophic scars are more commonly seen after surgeries, suture placements, or other skin damages. Scars can be treated using a variety of methods, including topical compounds, surgery, and lasers. The aim of this study is to evaluate the effects of plasma exeresis on the treatment of keloid scars. Methods: This experimental study was conducted on patients with keloid scars, defined as a treatment-resistant subtype of scars with extension beyond the primary skin defect and cauliflower appearance, in different parts of the body. The patients were treated with 2-to-3-session plasma exeresis. Scars were examined based on the Vancouver scar scale (VSS) before and 5 months after the treatment. Results: A total number of 24 scars were enrolled in this study. The number of patients was 16. There was a decrease in the mean thickness of keloids from 2.20 to 0.54 (P=0.000). The mean pigmentation and pliability scores decreased from 1.54 and 2.16 to 0.375 and 0.541, respectively (P=0.001, 000). There was a significant reduction in the keloid scar vascularity score from 1.666 to 0.541 (P=0.000). There was a decrease from 0.708 to 0.00 (P=0.004) in the mean itchiness score. After the intervention, the mean pain score was 0.000, compared to 0.7500 before the intervention (P=0.003). There was a decrease in the total score from 8.958 to 2.000 (P=0.000). Conclusion: The plasma exeresis procedure is effective in destroying small keloid scars. Furthermore, results in less itching and pain, as well as no significant complications or recurrences.

Background: Capnography has been the standard in the operating room for a long time now. When variable amounts of intrapulmonary shunt and intracardiac shunt are taken into account, arterial carbon dioxide (CO2) and end-tidal CO2 typically match rather well. The gap between arterial and end-tidal CO2 widens in patients with cardiopulmonary disorders. The current study sought to determine how arterial and end-tidal CO2 correlated with each other and with hemoglobin saturation both before and after pulmonary catheterization in a pediatric population with congenital heart disease. Methods: Fifty-seven children with congenital heart disease who underwent cardiopulmonary catheterization between March 2018 and April 2019 were included in a prospective cohort study at Children’s Medical Center. Arterial and end-tidal CO2, and hemodynamic variables were assessed prior to the catheterization procedure. Then the patients underwent catheterization, and before being extubated, these variables were again assessed and compared to the baseline levels. Results: End-tidal CO2 increased significantly in cyanotic patients following the catheterization procedure, and the difference between arterial and end-tidal CO2 decreased significantly. End-tidal CO2, arterial CO2, and their difference did not significantly change in non-cyanotic patients following the catheterization procedure. End-tidal and arterial CO2 were not significantly correlated in cyanotic patients (r=0.411, P=0.128), but they were correlated after the catheterization procedure (r=0.617, P=0.014). Conclusions: End-tidal CO2 can estimate arterial CO2 in non-cyanotic patients reasonably. End-tidal CO2 cannot be used to estimate arterial CO2 in cyanotic patients since there is no association. After cardiac defect correction, end-tidal CO2 can be a reliable predictor of arterial CO2.